Related Experiment Videos
[Clinical decision support: Is the number of medication errors reduced?].
Louise Isager Rabøl1, Jacob Anhøj, Anette Pedersen
1H:S Hvidovre Hospital, Dansk Selskab for Patientsikkerhed, København.
Ugeskrift for Laeger
|December 7, 2006
Summary
Clinical decision support (CDS) integrated with computer physician order entry (CPOE) significantly reduces medication errors. Advanced CDS systems show the strongest impact, though implementation can be time-consuming.
Area of Science:
- Health Informatics
- Medical Error Reduction
- Clinical Decision Support Systems
Context:
- Review of 22 clinical trials examining the efficacy of Clinical Decision Support (CDS) within Computer Physician Order Entry (CPOE) systems.
- Focus on the impact of CDS-CPOE on reducing medication errors in healthcare settings.
- Exploration of different generations of CDS technology and their effectiveness.
Purpose:
- To synthesize evidence on the effectiveness of CDS-CPOE in mitigating medication errors.
- To evaluate the impact of CDS system generations on error reduction.
- To identify limitations and challenges associated with CDS-CPOE implementation.
Summary:
- 21 out of 22 reviewed clinical trials demonstrated a reduction in medication errors following CDS implementation.
- The most significant improvements in medication error reduction were observed with 2nd and 3rd generation CDS systems.
- Challenges include the time-intensive nature of CPOE with CDS and the potential for introducing new errors; all trials exhibited design flaws.
Impact:
- Highlights the potential of CDS-CPOE to enhance patient safety by reducing medication errors.
- Suggests that newer generations of CDS technology offer greater benefits.
- Underscores the need for improved study designs and further research, particularly in establishing robust data sources for CDS in specific regions like Denmark.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:10Documentation of Nursing Diagnosis
The nurse documents nursing diagnoses and enters them into the patient record. The identified patient's nursing diagnosis is either written out with a plan of care or entered into the electronic health record.
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters assessment...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...